ANUHPHR91.70

Anuh Pharma Limited

· Pharma & Health
₹ CrorePeersAHCLWANBURYZIMLABBAJAJHCARETHEMISMEDLINCOLNVALIANTLABSIGACHIMcap ₹919 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
ANUHPHR
FY26
AHCL
FY26
WANBURY
FY25
ZIMLAB
FY26
Peer
Median
Valuation — at last close
P/E22.37×2.91×25.82×115.29×25.82× -13%
P/B2.61×0.37×13.30×2.48×2.48× +5%
EV/EBITDA14.03×2.82×12.55×27.72×12.55× +12%
Market Cap₹919 Cr₹94.5 Cr₹789 Cr₹734 Cr₹734 Cr +25%
Growth
Revenue CAGR 3Y5.46%-2.06%1.70%
Revenue CAGR 5Y10.29%10.29%
Net Income CAGR 3Y-27.91%-37.95%-32.93%
Revenue YoY (latest Q)3.93%24.47%31.25%27.86% -86%
Net Income YoY (latest Q)37.63%1200.41%-114.25%543.08% -93%
Profitability
EBITDA Margin8.00%27.63%12.73%8.02%12.73% -37%
Net Income Margin5.32%16.92%5.09%1.56%5.09% +5%
Return on Common Equity11.65%11.19%51.51%1.97%11.19% +4%
Return on Capital Employed14.21%17.26%26.33%2.87%17.26% -18%
Return on Assets7.36%7.78%7.38%1.08%7.38% -0%
Credit & Quality
Total Debt/Equity0.00×0.17×2.92×0.42×0.42× -100%
Interest Coverage106.58×12.30×1.71×0.76×1.71× +6133%
Scale — latest FY
Revenue / Total Income₹772 Cr₹172 Cr₹600 Cr₹374 Cr₹374 Cr +106%
Net Income₹41 Cr₹29.1 Cr₹30.5 Cr₹5.8 Cr₹29.1 Cr +41%
Total Assets₹557 Cr₹374 Cr₹414 Cr₹539 Cr₹414 Cr +35%
EPS₹4.1₹6.11₹9.32₹1.19₹6.11 -33%
Book Value per Share₹35.14₹47.94₹18.09₹55.36₹47.94 -27%
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.